Company intelligence / Profile preview

Ferrer

Barcelona, Barcelona, Spainferrer.com ↗

Ownership: Private
Employees: ~1900
Development stage: Phase 3

Overview

Ferrer has a broad portfolio of prescription drugs—mainly for hospital use—and self-care products. The company focuses on innovative therapies for severe illnesses in pulmonary vascular/interstitial lung disease and neurology. It has a strong R&D pipeline with both proprietary developments and licensed-in assets. Clinical results are not detailed in public sources but the company maintains over 80 clinical trials across its programs. In 2025 it was recognized as the highest-performing pharmaceutical company globally for social/environmental impact by B Corp standards.

Therapeutic areas: GastroenterologyPulmonologyPsychiatryCardiovascularDermatologyNeurology
Modalities: Small molecules (APIs and finished dosage forms)biologics (limited)food supplementsdiagnostics
Industry: Biotech

Drug pipeline

19 assets

sertaconazole nitrate

Approved

18 more assets in the full pipeline.

Request access →

Partnerships

Joint ventures/partnerships in San Francisco (US), Seoul (South Korea), Berlin (Germany) and Buenos Aires (Argentina)collaborations with academic institutions via EUREKA program participationlicensing partnerships not fully disclosed but likely present given international reach

Beyond the preview

Go deeper on Ferrer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferrer.

Explore the full profile